cerca CERCA
Mercoledì 21 Aprile 2021
Aggiornato: 05:42
Temi caldi


New report from the Global State of Tobacco Harm Reduction reveals only nine users of safer nicotine products for every 100 smokers worldwide - experts argue global tobacco control must adopt harm reduction to save lives

LONDON, Nov. 4, 2020 /PRNewswire/ -- Burning Issues: The Global State of Tobacco Harm Reduction (GSTHR) 2020 published by UK public health agency Knowledge Action Change (KAC) demonstrates an urgent need to scale up tobacco harm reduction, which enables smokers to switch to safer nicotine products, eliminating the smoke that causes death and disease.

Yuyu Pharma Announces the Introduction of its Global Anti-Corruption Management System

SEOUL, South Korea, Oct. 28, 2020 /PRNewswire/ -- On October 28, 2020, Yuyu Pharm (CEO Robert Wonsang Yu, KRX 000220) initiated steps to incorporate ISO 37001 Anti-bribery management system to strengthen the company's compliance system. During the introduction ceremony of ISO 37001 held at Yuyu Pharma's Seoul Office, CEO Robert Wonsang Yu kicked off the anti-bribery management system project and appointed Simon Kim, Director of Yuyu's Compliance Department, as the head of this project.

CStone and EQRx Enter Global Strategic Partnership for Two Immune Checkpoint Inhibitors: sugemalimab (anti-PD-L1) and CS1003 (anti-PD-1)

SUZHOU, China, Oct. 26, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) announced today an agreement to out-license ex-Greater China rights for two key late-stage immuno-oncology assets, sugemalimab (anti-PD-L1) and CS1003 (anti-PD-1), to EQRx, a biopharmaceutical company with an innovative business model that will allow these drugs to be competitively positioned in global markets against established treatments for the target indications.

Phosplatin Therapeutics Announces Presentation of Research into PT-112 Mechanism of Action at the 32nd EORTC-NCI-AACR Virtual Symposium

NEW YORK, Oct. 20, 2020 /PRNewswire/ -- Phosplatin Therapeutics LLC, a clinical stage pharmaceutical company focused on oncology therapeutics, today announced that data revealing novel mechanistic attributes of its lead candidate PT-112, an immunogenic cell death (ICD) inducer under Phase 2 development, will be presented at the 32nd Symposium of the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Resea...

Zentiva Reinforces Its Presence In Greece To Better Serve Greek People

PRAGUE, Oct. 19, 2020 /PRNewswire/ -- Zentiva reinforces its presence in Greece by signing a partnership with the company Lavipharm for representation, promotion, and distribution of its pharmaceutical products in Greece. With an established presence in Europe, Zentiva continues to strengthen its capabilities and service offering for people, by partnering with Lavipharm.

Enrolment of First Two Patients in PRISTINE Study with SELUTION SLR™ Sirolimus Drug Eluting Balloon

NYON, Switzerland, Oct. 11, 2020 /PRNewswire/ -- MedAlliance has announced enrolment of the first two patients in the PRISTINE registry with SELUTION SLR™ 018 DEB for the treatment of patients with Below The Knee disease (Chronic Limb Threatening Ischemia). This is the first DEB accepted by the FDA for its "Breakthrough Program". SELUTION SLR (Sustained Limus Release) is a novel sirolimus-eluting balloon that provides a controlled sustained release of drug, similar to a drug-eluting stent (DES).

Meet Zent2U at Virtual CPhi Festival of Pharma 2020

PRAGUE, Oct. 12, 2020 /PRNewswire/ -- The B2B Zent2U platform, powered by Zentiva, attends the online CPhI Festival of Pharma. The team will showcase its R&D pipeline assets for strategic partnerships through Zent2u. During this virtual congress, Zent2U representatives will meet with strategic stakeholders to discuss future collaboration leading to partnerships for success.

ora in
Prima pagina
Tag più usati
in questa pagina

change in emea region



leadership change

partner di canale

prodotti imdsoft

servizi metavision

sistema informativo

in Evidenza